drugset / Trial / NCT01703104

The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia

NCT01703104

Phase 1/2 Completed 150 enrolled Lagos State University
RandomizedCrossoverSingle-blindTreatment

Summary

The primary objective is to determine if there is a significant increase in the haematocrit value of patients on Jobelyn and standard therapy compared to those on standard therapy alone.

Timeline

Start
2012-01
Primary completion
2012-03
Completion
2012-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Jobelyn Traditional medicine (herbal / TCM) 250 mg
Comparator Proguanil Small molecule
Comparator folic acid Other / unclassified

Indications